Gottwald James T. sold $34K of TG (indirect holdings)

Gottwald James T. sold 4,196 indirectly-held shares of TREDEGAR CORP (TG) at an average of $8.02 ($8.00–$8.02) across 2 trades over 2026-05-28 to 2026-05-29.

Original reporting
SEC EDGAR · Gottwald James T.
Published Jun 1, 2026, 6:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Bearish
medium confidence
Mentioned
$TG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGBearishLow
01

Why it matters

The disclosed sale is the primary new fact; no prior reporting existed.

02

Market read

Small insider sell; limited immediate market effect.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 3/10Novelty 3/10Timing: same day filing

Background

SEC Form 4 filings provide the first public record of insider transactions.

Company-level read

Ticker impact

$TGBearishMedium confidence
Context

Form 4 disclosed a $33.7K open‑market sale by 10% owner James T. Gottwald.

Expected impact

likely slight downward pressure as market prices in the insider sell

Evidence & confidence

Sale amount is small relative to float; impact limited but could prompt short‑term sell‑off.

Market effects

Minimal; Tredegar operates in specialty chemicals, no sector‑wide impact.

None; US‑listed micro‑cap only.

None

Counterpoint

The sale could be routine liquidity need, not a bearish signal.

Key entities

  • Tredegar Corp

    Issuer of the Form 4.

  • James T. Gottwald

    10% owner who sold 4,196 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS • Net loss from continuing operations of $(2.8) million, or $(0.08) per diluted share, for the third quarter of 2026 compared to net income from continuing operations $7.1 million, or $0.20 per diluted share, for the third quarter of 20

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte